Validation of anti-Lipocalin-2 Nanobodies (anti-Lcn-2 Nbs) as anti-tumor treatment

Stijlemans, B. (Co-promotor), Van Ginderachter, J. (Promotor), Raes, G. (Promotor), Zivalj, M. ((PhD) Student). 4 Sept 2020